Rennova Health Inc (RNVA)
0.00
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Rennova Health Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.4803 |
| June 30, 2022 | -0.4985 |
| March 31, 2022 | -0.5075 |
| December 31, 2021 | |
| September 30, 2021 | -0.5963 |
| June 30, 2021 | -0.5445 |
| March 31, 2021 | -0.4163 |
| December 31, 2020 | -0.4237 |
| September 30, 2020 | -0.5085 |
| June 30, 2020 | -0.5846 |
| March 31, 2020 | -0.6413 |
| December 31, 2019 | -0.6405 |
| September 30, 2019 | -0.6985 |
| June 30, 2019 | -0.5874 |
| March 31, 2019 | -0.5412 |
| December 31, 2018 | -0.5275 |
| September 30, 2018 | -0.5869 |
| June 30, 2018 | -0.1415 |
| March 31, 2018 | -0.083 |
| December 31, 2017 | -0.3313 |
| September 30, 2017 | -0.626 |
| June 30, 2017 | -0.7222 |
| March 31, 2017 | -0.122 |
| December 31, 2016 | -0.6274 |
| September 30, 2016 | -0.9859 |
| Date | Value |
|---|---|
| June 30, 2016 | -1.241 |
| March 31, 2016 | -2.274 |
| September 30, 2015 | 0.0546 |
| June 30, 2015 | 0.0767 |
| March 31, 2015 | 0.0672 |
| December 31, 2014 | 0.4127 |
| September 30, 2014 | 0.2264 |
| June 30, 2014 | 0.162 |
| March 31, 2014 | 0.174 |
| December 31, 2013 | 0.1353 |
| September 30, 2013 | 0.1088 |
| June 30, 2013 | 0.0984 |
| March 31, 2013 | 0.0884 |
| December 31, 2012 | 0.0781 |
| September 30, 2012 | 0.0679 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 0.00 |
| September 30, 2011 | 0.00 |
| June 30, 2011 | 0.00 |
| March 31, 2011 | 0.00 |
| December 31, 2010 | 0.00 |
| September 30, 2010 | 0.00 |
| June 30, 2010 | 0.00 |
| March 31, 2010 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6985
Minimum
Sep 2019
-0.4163
Maximum
Mar 2021
-0.5483
Average
-0.5445
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.00 |
| IGC Pharma Inc | 0.0152 |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Protalix BioTherapeutics Inc | 0.6033 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 20.29M |
| Total Liabilities (Quarterly) | 50.20M |
| Shareholders Equity (Quarterly) | -29.91M |